NAROPIN is a Epidural; Infiltration; Perineural Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by General Injectables & Vaccines, Inc. The primary component is Ropivacaine Hydrochloride.
| Product ID | 52584-286_18b9c3f9-6ebf-4dcb-a5fd-5ac424f6ab0b | 
| NDC | 52584-286 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | NAROPIN | 
| Generic Name | Ropivacaine Hydrochloride | 
| Dosage Form | Injection, Solution | 
| Route of Administration | EPIDURAL; INFILTRATION; PERINEURAL | 
| Marketing Start Date | 2014-03-11 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020533 | 
| Labeler Name | General Injectables & Vaccines, Inc | 
| Substance Name | ROPIVACAINE HYDROCHLORIDE | 
| Active Ingredient Strength | 5 mg/mL | 
| Pharm Classes | Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2014-03-11 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020533 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2014-03-11 | 
| Ingredient | Strength | 
|---|---|
| ROPIVACAINE HYDROCHLORIDE | 5 mg/mL | 
| SPL SET ID: | 096c2693-8488-48c2-88ee-bf3df95c3f4c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0404-9924 | NAROPIN | ropivacaine hydrochloride | 
| 52584-286 | NAROPIN | NAROPIN | 
| 63323-285 | Naropin | Naropin | 
| 63323-286 | Naropin | Naropin | 
| 63323-287 | Naropin | Naropin | 
| 63323-288 | Naropin | Naropin | 
| 0143-9263 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 0143-9264 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 0143-9265 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 0143-9266 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 0409-9300 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | 
| 0409-9301 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | 
| 0409-9302 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | 
| 0409-9303 | Ropivacaine Hydrochloride | ROPIVACAINE HYDROCHLORIDE | 
| 0781-3140 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 0781-3142 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 17478-081 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 17478-082 | Ropivacaine Hydrochloride | Ropivacaine Hydrochloride | 
| 25021-652 | ropivacaine hydrochloride | ropivacaine hydrochloride | 
| 25021-653 | Ropivacaine Hydrochloride | ropivacaine hydrochloride | 
| 25021-671 | ropivacaine hydrochloride | ropivacaine hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() NAROPIN  78276844  not registered Dead/Abandoned  | 
        AstraZeneca AB  2003-07-21  | 
![]() NAROPIN  75229359  2130448 Live/Registered  | 
        FRESENIUS KABI USA, LLC  1997-01-22  | 
![]() NAROPIN  75085662  2148189 Live/Registered  | 
        FRESENIUS KABI USA, LLC  1996-04-09  | 
![]() NAROPIN  74716292  not registered Dead/Abandoned  | 
        ASTRA AKTIEBOLAG  1995-08-16  | 
![]() NAROPIN  74581013  2061834 Dead/Cancelled  | 
        ABRAXIS BIOSCIENCES, INC.  1994-10-03  | 
![]() NAROPIN  74157414  not registered Dead/Abandoned  | 
        AKTIEBOLAGET ASTRA  1991-04-12  |